APOBEC3G generates nonsense mutations in human T-cell leukemia virus type 1 proviral genomes in vivo.
Human T-cell leukemia virus type 1 (HTLV-1) induces cell proliferation after infection, leading to efficient transmission by cell-to-cell contact. After a long latent period, a fraction of carriers develop adult T-cell leukemia (ATL). Genetic changes in the tax gene in ATL cells were reported in about 10% of ATL cases. To determine genetic changes that may occur throughout the provirus, we determined the entire sequence of the HTLV-1 provirus in 60 ATL cases. Abortive genetic changes, including deletions, insertions, and nonsense mutations, were frequent in all viral genes except the HBZ gene, which is transcribed from the minus strand of the virus. G-to-A base substitutions were the most frequent mutations in ATL cells. The sequence context of G-to-A mutations was in accordance with the preferred target sequence of human APOBEC3G (hA3G). The target sequences of hA3G were less frequent in the plus strand of the HBZ coding region than in other coding regions of the HTLV-1 provirus. Nonsense mutations in viral genes including tax were also observed in proviruses from asymptomatic carriers, indicating that these mutations were generated during reverse transcription and prior to oncogenesis. The fact that hA3G targets the minus strand during reverse transcription explains why the HBZ gene is not susceptible to such nonsense mutations. HTLV-1-infected cells likely take advantage of hA3G to escape from the host immune system by losing expression of viral proteins.
Fan
Jun
J
Institute for Virus Research, Kyoto University, 53 Shogoin Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan. mmatsuok@virus.kyoto-u.ac.jp.
Ma
Guangyong
G
Nosaka
Kisato
K
Tanabe
Junko
J
Satou
Yorifumi
Y
Koito
Atsushi
A
Wain-Hobson
Simon
S
Vartanian
Jean-Pierre
JP
Matsuoka
Masao
M
D000071480:APOBEC-3G Deaminase; D001483:Base Sequence; D002460:Cell Line; D003564:Cytidine Deaminase / Q000235:genetics / Q000378:metabolism*; D017930:Genes, Reporter; D014644:Genetic Variation; D005822:Genetic Vectors; D016679:Genome, Viral; D015490:HTLV-I Infections / Q000821:virology*; D015368:Human T-lymphotropic virus 1 / Q000235:genetics* / Q000276:immunology / Q000472:pathogenicity; D006801:Humans; D015459:Leukemia-Lymphoma, Adult T-Cell / Q000821:virology*; D008969:Molecular Sequence Data; D016296:Mutagenesis; D009154:Mutation; D011533:Proviruses / Q000235:genetics*; D000098830:AICDA (Activation-Induced Cytidine Deaminase)
D000098830:AICDA (Activation-Induced Cytidine Deaminase); D000071480:APOBEC-3G Deaminase; C464924:APOBEC3G protein, human; D003564:Cytidine Deaminase
Nat Immunol. 2005 Jul;6(7):655-61
15970938
J Virol. 2004 Nov;78(21):11841-52
15479826
Nat Med. 2007 Apr;13(4):470-6
17401375
J Virol. 2000 Oct;74(20):9525-31
11000222
J Virol. 2007 May;81(9):4422-8
17287279
J Virol. 2002 Dec;76(24):12813-22
12438606
EMBO Rep. 2004 Jul;5(7):679-80
15229643
Annu Rev Immunol. 2008;26:317-53
18304004
Proc Natl Acad Sci U S A. 2006 Jan 17;103(3):720-5
16407133
Retrovirology. 2005 Mar 02;2:17
15743526
J Virol. 2007 Jun;81(11):5714-23
17344291
Int J Cancer. 2006 Jan 15;118(2):381-7
16052518
J Biol Chem. 2004 Aug 6;279(32):33177-84
15159405
Nat Struct Mol Biol. 2004 May;11(5):435-42
15098018
Cell Host Microbe. 2008 Jun 12;3(6):388-98
18541215
Blood. 1995 Dec 1;86(11):4243-9
7492783
Nat Med. 2003 Nov;9(11):1404-7
14528300
J Virol. 2008 Oct;82(19):9359-68
18653454
Proc Natl Acad Sci U S A. 2007 Feb 20;104(8):2915-20
17299050
Proc Natl Acad Sci U S A. 1989 May;86(9):3351-5
2541443
Nat Rev Immunol. 2004 Nov;4(11):868-77
15516966
EMBO J. 2004 Jun 16;23(12):2451-8
15152192
Science. 2005 Feb 18;307(5712):1061-5
15718460
Retrovirology. 2005 Oct 22;2:64
16242045
Int J Cancer. 2004 Apr 20;109(4):559-67
14991578
EMBO J. 2006 Apr 19;25(8):1741-52
16601696
Nat Rev Cancer. 2007 Apr;7(4):270-80
17384582
Virus Genes. 2001;23(2):123-35
11724264
Int Immunol. 1991 Aug;3(8):761-7
1911545
Cell. 1998 Apr 3;93(1):81-91
9546394
Cancer Res. 1997 Nov 1;57(21):4862-7
9354450
Curr Biol. 2004 Aug 10;14(15):1385-91
15296757
J Virol. 2008 Sep;82(17):8442-55
18596104
Blood. 1996 Oct 15;88(8):3065-73
8874205
J Virol. 2006 Nov;80(21):10683-91
16943297
J Gen Virol. 2005 Sep;86(Pt 9):2489-2494
16099907
J Virol. 1995 Apr;69(4):2611-6
7884912
Proc Natl Acad Sci U S A. 2005 Jan 4;102(1):63-8
15623561
Oncogene. 2005 Sep 5;24(39):6005-15
16155607
Retrovirology. 2005 May 19;2:32
15943885
Science. 2003 Nov 7;302(5647):1056-60
14564014
Virology. 2005 Mar 15;333(2):374-86
15721369
J Virol. 2002 Sep;76(18):9389-97
12186921
Proc Natl Acad Sci U S A. 1995 Feb 14;92(4):1057-61
7862633
Nat Med. 2006 Apr;12(4):466-72
16550188
J Neurovirol. 1995 Sep;1(3-4):286-94
9222367
Retrovirology. 2005 Mar 02;2:16
15743528
Blood. 2001 Feb 15;97(4):987-93
11159527
Int J Hematol. 2003 Nov;78(4):280-96
14686485